381 related articles for article (PubMed ID: 18418595)
1. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.
Braun JJ; Kessler R; Constantinesco A; Imperiale A
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1537-43. PubMed ID: 18418595
[TBL] [Abstract][Full Text] [Related]
2. Interest of [18F]FDG PET/CT for treatment efficacy assessment in aggressive phenotype of sarcoidosis with special emphasis on sinonasal involvement.
Imperiale A; Riehm S; Braun JJ
Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):177-86. PubMed ID: 23598684
[TBL] [Abstract][Full Text] [Related]
3. Visual findings of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cardiac sarcoidosis.
Ito K; Okazaki O; Morooka M; Kubota K; Minamimoto R; Hiroe M
Intern Med; 2014; 53(18):2041-9. PubMed ID: 25224185
[TBL] [Abstract][Full Text] [Related]
4. The Utility of
Chen H; Jin R; Wang Y; Li L; Li K; He Y
Biomed Res Int; 2018; 2018():1823710. PubMed ID: 29686996
[TBL] [Abstract][Full Text] [Related]
5. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
Ohira H; Tsujino I; Ishimaru S; Oyama N; Takei T; Tsukamoto E; Miura M; Sakaue S; Tamaki N; Nishimura M
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):933-41. PubMed ID: 18084757
[TBL] [Abstract][Full Text] [Related]
6. Imaging in sinonasal sarcoidosis: CT, MRI, 67Gallium scintigraphy and 18F-FDG PET/CT features.
Braun JJ; Imperiale A; Riehm S; Veillon F
J Neuroradiol; 2010 Jul; 37(3):172-81. PubMed ID: 19959235
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis.
Langah R; Spicer K; Gebregziabher M; Gordon L
J Nucl Cardiol; 2009; 16(5):801-10. PubMed ID: 19548047
[TBL] [Abstract][Full Text] [Related]
8. Use of PET-CT for the assessment of treatment results in patients with sarcoidosis.
Yakar A; Yakar F; Sezer M; Bayram M; Erdoğan EB; Özkan D; Özçelik HK; Tabak L
Wien Klin Wochenschr; 2015 Apr; 127(7-8):274-82. PubMed ID: 25447964
[TBL] [Abstract][Full Text] [Related]
9.
Chauvelot P; Skanjeti A; Jamilloux Y; de Parisot A; Broussolle C; Denis P; Ramackers JM; Giammarile F; Kodjikian L; Seve P
Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
Yokoyama R; Miyagawa M; Okayama H; Inoue T; Miki H; Ogimoto A; Higaki J; Mochizuki T
Int J Cardiol; 2015 Sep; 195():180-7. PubMed ID: 26043154
[TBL] [Abstract][Full Text] [Related]
11. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
[TBL] [Abstract][Full Text] [Related]
12. The impact of 18F-FDG PET/CT in patients with liver metastases.
Chua SC; Groves AM; Kayani I; Menezes L; Gacinovic S; Du Y; Bomanji JB; Ell PJ
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1906-14. PubMed ID: 17713766
[TBL] [Abstract][Full Text] [Related]
13. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.
Sobic-Saranovic D; Grozdic I; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko V; Saranovic D; Djuric-Stefanovic A; Masulovic D; Odalovic S; Ilic-Dudvarski A; Popevic S; Pavlovic S; Obradovic V
J Nucl Med; 2012 Oct; 53(10):1543-9. PubMed ID: 22879080
[TBL] [Abstract][Full Text] [Related]
14. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L
Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
[TBL] [Abstract][Full Text] [Related]
15. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
Wisenberg G; Thiessen JD; Pavlovsky W; Butler J; Wilk B; Prato FS
J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887
[TBL] [Abstract][Full Text] [Related]
16. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
17. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic yield of whole-body
Saleh JK; Barkmeier D; Frey KA; Davenport MS
J Nucl Cardiol; 2023 Oct; 30(5):1773-1781. PubMed ID: 36829085
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of myocardial washout of
Suzuki M; Izawa Y; Fujita H; Miwa K; Takahashi Y; Toh H; Toba T; Fujiwara S; Hashimura H; Kono AK; Hirata KI
Ann Nucl Med; 2022 Jun; 36(6):544-552. PubMed ID: 35303274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
